Connect with us

AI Insights

FSU experts available to discuss the role of artificial intelligence in health care

Published

on


Professors Zhe He and Delaney La Rosa are proponents of the ways that artificial intelligence is transforming health care.

On Sept. 3, the United States House Committee on Energy and Commerce Subcommittee on Health held a hearing on the critical issue of advancing American health care through artificial intelligence.

Championed by many organizations, including the American Medical Association, the use of AI in health care is seen as one of the new technology’s most important benefits. It is utilized in ways that improve patient health outcomes, provide surgical precision, enhance diagnostic accuracy and much more.

Florida State University’s Zhe He, a professor in the College of Communication and Information and director of the Institute for Successful Longevity, recently developed a study highlighting AI’s impact in diagnostic accuracy, personalized treatment plans, interpreting medical images, streamlining operations and supporting remote patient monitoring among many successful initiatives.

His research lies in the intersection of biomedical and health informatics, artificial intelligence, and big data analytics. He is an elected fellow of the International Academy of Health Sciences Informatics (IAHSI) and the American Medical Informatics Association (AMIA).

“AI has already reshaped health care in tangible ways,” He said of the new technology’s transformative impact. “We now use AI to analyze electronic health records, medical images, and even predict differential diagnosis, mortality and hospital readmissions. These tools don’t replace clinicians, but they extend their reach and help reduce diagnostic delays, personalize treatments and improve efficiency. Importantly, AI is also opening doors to rural communities by enabling new models of remote monitoring and telehealth support.”

Delaney La Rosa, teaching professor at the College of Nursing, is an educator and academic leader whose work bridges clinical practice, digital innovation, and equity-centered curriculum design. She is a nationally recognized researcher and speaker on the ethical application of AI in nursing and education.

La Rosa has expertise in health care informatics, the use of AI in health care and the integration of AI in health care education. She explores how emerging technologies can be aligned with human-centered, accessible approaches to teaching and care.

“The area that AI is transforming health care most is in the preemptive area,” La Rosa said. “We’re finding out when a patient is about to decline or when a patient is about to go septic. We are looking through data across populations.”

“In rural primary care clinics, we know that these areas are stretched for staffing,” she added. “What these AI tools can do is they can use the data across that primary office’s entire population of patients and, using the training that it was trained with, can identify patients who are most likely to develop conditions or who are most likely to benefit from preventive programs.”

Media interested in learning about the multitude of ways AI is advancing health care can reach out to Zhe He at zhe@fsu.edu and Delaney La Rosa at dwl25b@fsu.edu.


Zhe He, professor in the College of Communication and Information and director of the Institute for Successful Longevity

1. We’ve seen enormous impacts already, but what other areas in health care do you feel AI can potentially change in the future?

 I see three big frontiers:

 Patient engagement: Tools that help people better understand their lab results, medications and care plans can empower them to make more informed choices.

 Aging and chronic disease management: With our aging population, AI can play a vital role in predicting risks, supporting caregivers and promoting adherence to treatment.

 Clinical research and drug discovery: AI is accelerating trial recruitment, optimizing study design and uncovering new therapeutic targets. Over the next decade, I think these areas will be transformed just as radiology has been over the past decade.

2. How has AI impacted the work you do?

My research focuses on making health information more accessible and actionable with informatics and AI. For example, my team is developing LabGenie, a GenAI-powered system that helps older adults and caregivers interpret lab test results and generate personalized questions for their clinicians. We are also developing AI-based systems to promote adherence to cognitive training, support post-transplant care and identify strategies for HIV prevention and management for young adults. Across all of this work, AI is not an end in itself—it’s a means to improve patient engagement, adherence to treatment and shared decision making.

Delaney La Rosa, teaching professor, College of Nursing

1. What kinds of advancements has the College of Nursing made as it invests heavily in AI?

From my personal perspective, the biggest contribution we are making for AI is two-fold: The first is we lead the nation. We are the first with a degree in health care AI for our students. There is a big juggernaut out there — we must quickly learn how to use AI and then we must quickly teach our students how to use AI and use it ethically, which is another big issue, and then graduate workforce-ready individuals. Not only do we have our degree program, but we are about to release a microcredential where we develop six total courses for a certificate program called Nursing Essentials of Responsible AI. We are also beginning our postgraduate certificate. We’re leading the nation in graduating. We’re getting workforce-ready students.

 The second thing is we are leading an AI consortium and having our first launch summit that’s happening in Orlando on Sept. 17 – the Nursing and AI Innovation Consortium Launch Summit. And what that means is that we have leaders from across industries — research, practice, higher education — who are coming together, and we’re going to sit at the table and determine where we want to go next in AI.

2. How critical is the role you play in terms of AI education?

 I think the most important thing to me is our foundational essentials course. This course gives you a good grounding in the things that are not going to really change much in AI. It’s that base understanding so we can know the language. One thing that nurses are great at is being able to assess the data and information that’s coming out to see if it’s quality and it’s scientific. But you can’t do that in AI unless you have a basic understanding of how it works.



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

AI Insights

Mapping the power of AI across the patient journey

Published

on


Artificial intelligence (AI) is rapidly transforming clinical care, offering healthcare leaders new tools to improve workflows through automation and enhance patient outcomes with more accurate diagnoses and personalized treatments. This resource provides a framework for understanding how AI is applied across the patient journey, from pre-visit interactions to post‑visit monitoring and ongoing care. It focuses on actionable use cases to help healthcare organizations evaluate AI technologies holistically, balance innovation with feasibility, and navigate the evolving landscape of AI in healthcare.

For a deeper exploration of any specific use case featured in this infographic, check out our comprehensive compendium. It offers detailed insights into these technologies, including their benefits, implementation considerations, and evolving role in healthcare.



Source link

Continue Reading

AI Insights

Artificial intelligence (AI) for trusted computing and cyber security

Published

on


Summary points:

  • New software security system enhances protection for NVIDIA Jetson-powered embedded AI systems.
  • Secures AI models and sensitive data through encrypted APIs, process isolation, and secure OS features.
  • Includes anti-rollback protection, automatic OS recovery, and centralized web-based monitoring tools for edge devices.

TAIPEI, Taiwan – AAEON Technology in Taipei, Taiwan, is introducing a software security system for the company’s embedded artificial intelligence (AI) systems powered by NVIDIA Jetson system-on-modules.

The cyber security system is built on a three-tiered architecture with components that protect data at the edge and in the cloud. It is available as part of the board support package for SKUs of AAEON’s BOXER-8621AI, BOXER-8641AI-Plus, and the BOXER-8651AI-Plus Edge AI systems.

The most notable component of this trusted computing product is a trusted execution environment (TEE) named MAZU to protect AI models and application data by separating files, processes, and algorithms within protected execution zones.

Sensitive assets

Using MAZU enables users to isolate machine learning algorithms while running standard applications. It also gives access to sensitive assets through certified APIs with encrypted communications, secure OS, and certificate validation.

Other mechanisms include anti-restore protection, A/B redundancy partitioning, and disk lock to prevent hackers from reverting system software to previous versions. It reverts to a stable OS image if a device fails, and encrypts data storage on edge devices.

The package contains server-side management tools to manage edge devices at the server, including a web-based UI that monitors several edge systems from one server.

For more information contact AAEON online at https://www.aaeon.com/en/article/detail/software_security_framework.



Source link

Continue Reading

AI Insights

AI rollout in NHS hospitals faces major challenges

Published

on


Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools and staff training, finds a major new UK study led by UCL researchers. 

Authors of the study, published in The Lancet eClinicalMedicine, say the findings should provide timely and useful learning for the UK Government, whose recent 10-year NHS plan identifies digital transformation, including AI, as a key platform to improving the service and patient experience. 

In 2023, NHS England launched a programme to introduce AI to help diagnose chest conditions, including lung cancer, across 66 NHS hospital trusts in England, backed by £21 million in funding. The trusts are grouped into 12 imaging diagnostic networks: these hospital networks mean more patients have access to specialist opinions. Key functions of these AI tools included prioritising critical cases for specialist review and supporting specialists’ decisions by highlighting abnormalities on scans.

Funded by the National Institute for Health and Care Research (NIHR), this research was conducted by a team from UCL, the Nuffield Trust, and the University of Cambridge, analysing how procurement and early deployment of the AI tools went. The study is one of the first studies to analyse real-world implementation of AI in healthcare.

Evidence from previous studies¹, mostly laboratory-based, suggested that AI might benefit diagnostic services by supporting decisions, improving detection accuracy, reducing errors and easing workforce burdens.

In this UCL-led study, the researchers reviewed how the new diagnostic tools were procured and set up through interviews with hospital staff and AI suppliers, identifying any pitfalls but also any factors that helped smooth the process.

They found that setting up the AI tools took longer than anticipated by the programme’s leadership. Contracting took between four and 10 months longer than anticipated and by June 2025, 18 months after contracting was meant to be completed, a third (23 out of 66) of the hospital trusts were not yet using the tools in clinical practice.

Key challenges included engaging clinical staff with already high workloads in the project, embedding the new technology in ageing and varied NHS IT systems across dozens of hospitals and a general lack of understanding, and scepticism, among staff about using AI in healthcare.

The study also identified important factors which helped embed AI including national programme leadership and local imaging networks sharing resources and expertise, high levels of commitment from hospital staff leading implementation, and dedicated project management.

The researchers concluded that while “AI tools may offer valuable support for diagnostic services, they may not address current healthcare service pressures as straightforwardly as policymakers may hope” and are recommending that NHS staff are trained in how AI can be used effectively and safely and that dedicated project management is used to implement schemes like this in the future.

First author Dr Angus Ramsay (UCL Department of Behavioural Science and Health) said: “In July ministers unveiled the Government’s 10-year plan for the NHS, of which a digital transformation is a key platform.

“Our study provides important lessons that should help strengthen future approaches to implementing AI in the NHS.

“We found it took longer to introduce the new AI tools in this programme than those leading the programme had expected.

“A key problem was that clinical staff were already very busy – finding time to go through the selection process was a challenge, as was supporting integration of AI with local IT systems and obtaining local governance approvals. Services that used dedicated project managers found their support very helpful in implementing changes, but only some services were able to do this.

“Also, a common issue was the novelty of AI, suggesting a need for more guidance and education on AI and its implementation.

“AI tools can offer valuable support for diagnostic services, but they may not address current healthcare service pressures as simply as policymakers may hope.”

The researchers conducted their evaluation between March and September last year, studying 10 of the participating networks and focusing in depth on six NHS trusts. They interviewed network teams, trust staff and AI suppliers, observed planning, governance and training and analysed relevant documents.

Some of the imaging networks and many of the hospital trusts within them were new to procuring and working with AI.

The problems involved in setting up the new tools varied – for example, in some cases those procuring the tools were overwhelmed by a huge amount of very technical information, increasing the likelihood of key details being missed. Consideration should be given to creating a national approved shortlist of potential suppliers to facilitate procurement at local level, the researchers said.

Another problem was initial lack of enthusiasm among some NHS staff for the new technology in this early phase, with some more senior clinical staff raising concerns about the potential impact of AI making decisions without clinical input and on where accountability lay in the event a condition was missed. The researchers found the training offered to staff did not address these issues sufficiently across the wider workforce – hence their call for early and ongoing training on future projects.

In contrast, however, the study team found the process of procurement was supported by advice from the national team and imaging networks learning from each other. The researchers also observed high levels of commitment and collaboration between local hospital teams (including clinicians and IT) working with AI supplier teams to progress implementation within hospitals.

In this project, each hospital selected AI tools for different reasons, such as focusing on X-ray or CT scanning, and purposes, such as to prioritise urgent cases for review or to identify potential symptoms.


The NHS is made up of hundreds of organisations with different clinical requirements and different IT systems and introducing any diagnostic tools that suit multiple hospitals is highly complex. These findings indicate AI might not be the silver bullet some have hoped for but the lessons from this study will help the NHS implement AI tools more effectively.”


Naomi Fulop, Senior Author, Professor UCL Department of Behavioural Science and Health

Limitations

While the study has added to the very limited body of evidence on the implementation and use of AI in real-world settings, it focused on procurement and early deployment. The researchers are now studying the use of AI tools following early deployment when they have had a chance to become more embedded. Further, the researchers did not interview patients and carers and are therefore now conducting such interviews to address important gaps in knowledge about patient experiences and perspectives, as well as considerations of equity.

Source:

Journal reference:

Ramsay, A. I. G., et al. (2025). Procurement and early deployment of artificial intelligence tools for chest diagnostics in NHS services in England: a rapid, mixed method evaluation. eClinicalMedicine. doi.org/10.1016/j.eclinm.2025.103481



Source link

Continue Reading

Trending